Let us revisit Dr Menons remarks and consider what they mean to the P21 timeline

Dr. Menon continued, "Some very exciting times are approaching as we expect to reach Maximum Tolerated Dose between the sixth and ninth cohorts. We also look forward to data on the p21 biomarker, which was not available for the ASCO meeting as the laboratory moves the samples into queue, in the coming weeks. As can clearly be seen in the poster, at this time ten patients have been treated with Kevetrin at low doses. Five patients have received more than one cycle of Kevetrin, including one patient who has already completed seven dosing cycles. This lends to our enthusiasm about the potential of Kevetrin and our sanguine outlook for the second half of the year."

Here is the KEY

on the p21 biomarker, which was not available for the ASCO meeting as the laboratory moves the samples into queue,in the coming weeks

This clearly tells us that our lab samples DO NOT YET have a place IN LINE....and that there is A LINE

Further its says that after some number of UNSPECIFIED WEEKS we will FINALLY HAVE a place in the LINE

and thereafter have to PROGRESS thru a Queue until it becomes OUR TURN.

My conslusion REMAINS that JULY is a WASTELAND